Displaying items by tag: department of neurology

The National Ataxia Foundation has named UAB a Center of Excellence. The designation is awarded to regional centers providing comprehensive care and services for individuals affected by ataxia and their families.
In a mouse model, border-associated macrophages, not microglia, were essential for the neuroinflammation that precedes neurodegradation. Targeting this subset could be a disease-modifying therapy in neurodegenerative disease.
UAB scientist aims to inspire children from underrepresented backgrounds to pursue a career in science and help them understand that achieving their passions is possible.
UAB was involved in clinical trials that led to an accelerated approval of the drug lecanemab, commercially known as Leqembi, in January 2023. A UAB Alzheimer’s expert discusses the therapy and what full approval means for the AD field.
As a caregiver to his adult son, Anderson was able to earn his master’s degree at UAB and turn his interest in magic arts into deception research and a second career in academics.
Neuroengineering blends engineering principles with neuroscience to find better ways to treat neurological conditions and to build on understanding how the brain and nervous system function.
The findings indicate that inflammation is present in the brain early in the disease’s progression, but how inflammation affects disease progression remains unknown.
The clinic, supported by an Alabama Department of Commerce Innovation Fund grant, makes it easier for patients to get all the services they need in one place.
The study, utilizing the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease.
The AHEAD study is looking to recruit people at risk for developing Alzheimer’s disease for a new study.
The gift will advance the use of induced pluripotent stem cells as a potential therapy for Alzheimer’s disease.
An internationally recognized clinician and researcher in Parkinson’s disease, UAB’s David Standaert, M.D., Ph.D., has been honored with a lifetime achievement award from the Parkinson’s Association of Alabama.
The new technique to predict seizure clusters could, if confirmed, have a profound impact on patients with drug-resistant epilepsy who are prone to seizure clusters. 
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.
Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.
With the number of Americans with dementia expected to increase dramatically, UAB’s new brain health clinics point the way to improving brain health over a lifespan.
Page 1 of 13